应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BMY 施贵宝
休市中 11-06 16:00:00 EST
62.14
-0.99
-1.57%
盘后
62.35
+0.21
+0.34%
19:57 EST
最高
63.06
最低
61.32
成交量
979.59万
今开
61.46
昨收
63.13
日振幅
2.76%
总市值
1,265亿
流通市值
1,265亿
总股本
20.36亿
成交额
6.10亿
换手率
0.48%
流通股本
20.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜施贵宝盘中上涨3.12%，投行下调目标价后市场仍消化业绩利好
行情直击 · 11-04
异动解读｜施贵宝盘中上涨3.12%，投行下调目标价后市场仍消化业绩利好
异动解读｜施贵宝盘中上涨3.14%，Q3业绩超预期且上调全年营收指引
行情直击 · 10-30
异动解读｜施贵宝盘中上涨3.14%，Q3业绩超预期且上调全年营收指引
百时美施贵宝不会推进PRX019的临床开发。
智通财经 · 10-30
百时美施贵宝不会推进PRX019的临床开发。
新药组合发力 施贵宝(BMY.US)Q3业绩超预期
智通财经 · 10-29
新药组合发力 施贵宝(BMY.US)Q3业绩超预期
百时美施贵宝第三季度营收增长4.3% 上调全年营收指引
南方财经网 · 10-29
百时美施贵宝第三季度营收增长4.3% 上调全年营收指引
百时美施贵宝Q3调整后每股收益1.35美元 高于预期
格隆汇 · 10-29
百时美施贵宝Q3调整后每股收益1.35美元 高于预期
百时美施贵宝第三季度业绩超预期，上调2026年营收预期，盘前股价上涨2.2%。
智通财经 · 10-29
百时美施贵宝第三季度业绩超预期，上调2026年营收预期，盘前股价上涨2.2%。
百时美施贵宝上调2026年营收预期，三季度新药需求向好
智通财经 · 10-29
百时美施贵宝上调2026年营收预期，三季度新药需求向好
百时美施贵宝第三季度营收130.7亿美元，预期为127.1亿美元。
智通财经 · 10-29
百时美施贵宝第三季度营收130.7亿美元，预期为127.1亿美元。
国内外两大巨头纷纷大动作，行业传统范式正在重塑！机构建议把握商业验证与临床验证两条主线，产业链相关公司梳理
同花顺 · 10-28
国内外两大巨头纷纷大动作，行业传统范式正在重塑！机构建议把握商业验证与临床验证两条主线，产业链相关公司梳理
派珀·桑德勒将百时美施贵宝目标价从82美元下调至78美元。
智通财经 · 10-26
派珀·桑德勒将百时美施贵宝目标价从82美元下调至78美元。
生物科技公司和百时美施贵宝公布了 Pumitamig 在免疫治疗联合化疗后进展的晚期非小细胞肺癌中的全球 2 期积极数据
智通财经 · 10-25
生物科技公司和百时美施贵宝公布了 Pumitamig 在免疫治疗联合化疗后进展的晚期非小细胞肺癌中的全球 2 期积极数据
CLDN18.2靶向ADC 3期研究达到双主要终点；双靶点ADC 3期结果积极……
同花顺 · 10-24
CLDN18.2靶向ADC 3期研究达到双主要终点；双靶点ADC 3期结果积极……
百时美施贵宝披露早期多发性硬化症试验中出现患者死亡；股价下跌2.5%。
智通财经 · 10-23
百时美施贵宝披露早期多发性硬化症试验中出现患者死亡；股价下跌2.5%。
百时美施贵宝表示，一名多发性硬化症患者在CAR-T研究中死于脓毒性肺炎。
智通财经 · 10-23
百时美施贵宝表示，一名多发性硬化症患者在CAR-T研究中死于脓毒性肺炎。
TEMPUS AI：百时美施贵宝将获得该公司多模式肿瘤学数据的授权，授权期限至2031年，以支持生物和临床洞察的识别。
智通财经 · 10-23
TEMPUS AI：百时美施贵宝将获得该公司多模式肿瘤学数据的授权，授权期限至2031年，以支持生物和临床洞察的识别。
百时美施贵宝公司：在第三阶段乳腺癌研究中，伊沙贝木单抗将疾病进展或死亡的风险降低了59%。
智通财经 · 10-23
百时美施贵宝公司：在第三阶段乳腺癌研究中，伊沙贝木单抗将疾病进展或死亡的风险降低了59%。
异动解读｜施贵宝盘中上涨3.03%，机构看好第三季度收入表现
行情直击 · 10-23
异动解读｜施贵宝盘中上涨3.03%，机构看好第三季度收入表现
财报前瞻 | 施贵宝本季度营收预计增7.96%，机构观点偏谨慎
财报Agent · 10-22
财报前瞻 | 施贵宝本季度营收预计增7.96%，机构观点偏谨慎
异动解读｜施贵宝盘中上涨3.46%，机构看好第三季度收入表现
行情直击 · 10-20
异动解读｜施贵宝盘中上涨3.46%，机构看好第三季度收入表现
加载更多
公司概况
公司名称：
施贵宝
所属市场：
NYSE
上市日期：
--
主营业务：
百时美施贵宝公司于1933年8月在美国德拉瓦州注册成立，源自于1887年在纽约创办的企业，并在1989年因合并而重命名。作为一家生物制药公司，百时美施贵宝专注于创新药物的发现、开发、许可、生产、营销和销售，以对抗严重疾病。公司的战略方法结合了大型制药公司的资源和规模，以及生物技术行业特有的灵活性和创新重点。百时美施贵宝优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物，旨在提供长期价值和竞争优势。作为全球研究型制药公司，百时美施贵宝的产品在全球范围内销售，服务于包括批发商、分销商和特药药房在内的多种实体，并在多个国家保持着重要的生产运营。
发行价格：
--
{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":62.14,"timestamp":1793998800000,"preClose":63.13,"halted":0,"volume":9795938,"hourTrading":{"tag":"盘后","latestPrice":62.35,"preClose":62.14,"latestTime":"19:57 EST","volume":1498038,"amount":93088645.0442,"timestamp":1794013075811,"change":0.21,"changeRate":0.003379,"amplitude":0.003379},"delay":0,"changeRate":-0.015681926184064658,"floatShares":2035753027,"shares":2035753027,"eps":4.512919,"marketStatus":"休市中","change":-0.99,"latestTime":"11-06 16:00:00 EST","open":61.46,"high":63.06,"low":61.32,"amount":610261820.614968,"amplitude":0.027562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.512919,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":63.13,"dividendRate":0.040536,"preHourTrading":{"tag":"盘前","latestPrice":61.42,"preClose":63.13,"latestTime":"09:29 EST","volume":25375,"amount":1572556.2475,"timestamp":1793975399999,"change":-1.71,"changeRate":-0.027087,"amplitude":0.033764},"postHourTrading":{"tag":"盘后","latestPrice":62.35,"preClose":62.14,"latestTime":"19:57 EST","volume":1498038,"amount":93088645.0442,"timestamp":1794013075811,"change":0.21,"changeRate":0.003379,"amplitude":0.003379},"volumeRatio":0.859987103284332,"optionData":{"bulkOrders":[{"symbol":"BMY","call":false,"expireDate":1793941200000,"strike":"60.0","timestamp":1793975417238,"price":0.1,"volume":3000,"amount":30000,"type":"-"},{"symbol":"BMY","call":false,"expireDate":1793941200000,"strike":"59.0","timestamp":1793975415967,"price":0.02,"volume":3000,"amount":6000,"type":"*"}]},"impliedVol":0.345,"impliedVolPercentile":0.8207},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"1135488752","title":"异动解读｜施贵宝盘中上涨3.12%，投行下调目标价后市场仍消化业绩利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1135488752","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135488752?lang=zh_cn&edition=full","pubTime":"2026-11-04 23:17","pubTimestamp":1793805452,"startTime":"0","endTime":"0","summary":"11月4日，施贵宝盘中上涨3.12%，报62.5美元，成交额9341.83万美元。不过，公司同时将全年调整后每股收益预期下调至6.35至6.55美元；且最新卖方动态显示，高盛已将目标价由63美元下调至61美元。当前股价上行，说明市场更关注收入韧性与增长产品放量表现。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"施贵宝业绩超预期，股价逆势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191525023","title":"异动解读｜施贵宝盘中上涨3.14%，Q3业绩超预期且上调全年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1191525023","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191525023?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:54","pubTimestamp":1793368455,"startTime":"0","endTime":"0","summary":"10月30日，施贵宝盘中上涨3.14%，报63.3825美元，成交额7583.5万美元。消息面上，公司此前披露第三季度业绩超出市场预期，并上调全年营收指引，成为股价走强的主要催化。数据显示，施贵宝第三季度营收130.69亿美元，同比增长7%，调整后每股收益1.35美元，均高于市场预期；公司将全年营收指引上调至497.5亿至502.5亿美元。不过，公司同时将全年调整后每股收益预期下调至6.35至6.55美元。另据最新披露，公司不会推进PRX019的临床开发。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"施贵宝业绩超预期，上调全年营收指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679161239","title":"百时美施贵宝不会推进PRX019的临床开发。","url":"https://stock-news.laohu8.com/highlight/detail?id=2679161239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679161239?lang=zh_cn&edition=full","pubTime":"2026-10-30 04:25","pubTimestamp":1793305507,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJT1NW94.SGD","LU0321505439.SGD","LU2596442595.SGD","LU1868836914.USD","BK4588","IE00BSNM7G36.USD","LU0061475181.USD","IE0002141913.USD","LU0306807586.USD","LU1670710661.SGD","LU0225284248.USD","LU1718418525.SGD","LU0096364046.USD","LU0114720955.EUR","LU2125154935.USD","LU1093756325.SGD","LU1585245621.USD","LU1868836757.USD","IHE","BK4585","LU1074936037.SGD","LU2125154778.USD","LU1670711123.USD","LU1571399168.USD","LU1261432733.SGD","LU0225771236.USD","LU2133065610.SGD","LU1868836591.USD","LU1868837136.USD","FTXH","LU1868837300.USD","LU2242646821.SGD","IE00BFXG1179.USD","LU0306806265.USD","LU1989771016.USD","LU1670711040.USD","BK4532","IE00B2B36J28.USD","LU0321505868.SGD","LU1236620834.HKD","IE0009355771.USD","BMY","LU1883839398.USD","LU0058720904.USD","LU1430594728.SGD","LU1093756168.USD","LU0868494617.USD","LU0267386448.USD","LU0882574055.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679405082","title":"新药组合发力 施贵宝(BMY.US)Q3业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2679405082","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679405082?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:25","pubTimestamp":1793273115,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四美股盘前，施贵宝公布2026年第三季度财报。得益于“增长组合”产品持续放量，公司Q3业绩超出预期，并上调了全年营收指引。数据显示，施贵宝第三季度总营收为130.69亿美元，同比增长7%，好于市场预期。利润率方面，受产品结构变化及一笔合同终止相关的一次性费用影响，GAAP毛利率从去年同期的71.9%下降至68.3%，非GAAP毛利率从72.9%降至68.4%。财报公布后，施贵宝股价盘前涨1.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1868837136.USD","LU2596442595.SGD","FTXH","LU0432979614.USD","LU0306807586.USD","IE0002141913.USD","LU1032466523.USD","BK4585","LU1670711040.USD","LU2360032135.SGD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU1430594728.SGD","LU2125154935.USD","LU0225284248.USD","LU0267386448.USD","LU1670710588.SGD","LU1670711123.USD","BK4588","IE00BJT1NW94.SGD","LU0868494617.USD","BMY","LU2242652126.USD","LU1291159041.SGD","IHE","LU0237698245.USD","LU1883839398.USD","LU1093756168.USD","LU0061475181.USD","LU0321505439.SGD","LU2242646821.SGD","BK4559","BK4581","LU1868836591.USD","LU1868837300.USD","LU0321505868.SGD","LU1718418525.SGD","LU1868836914.USD","BK4007","IE00BSNM7G36.USD","LU0058720904.USD","LU0306806265.USD","LU0882574055.USD","IE0009355771.USD","IE00BFXG1179.USD","LU1670710661.SGD","IE00BFTCPJ56.SGD","BK4534","LU0985481810.HKD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679140503","title":"百时美施贵宝第三季度营收增长4.3% 上调全年营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2679140503","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679140503?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:11","pubTimestamp":1793272260,"startTime":"0","endTime":"0","summary":"南方财经10月29日电，百时美施贵宝第三季度营收130.7亿美元，同比增长4.3%，高于市场预期的127.2亿美元；调整后每股收益1.35美元，高于市场预期的1.09美元。公司预计2026年全年营收为497.5亿至502.5亿美元，调整后每股收益为6.35至6.55美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610293914579265.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610293914579265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679036264","title":"百时美施贵宝Q3调整后每股收益1.35美元 高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2679036264","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679036264?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:09","pubTimestamp":1793272177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1585245621.USD","LU2596442595.SGD","LU1670710661.SGD","LU1883839398.USD","BK4581","LU0058720904.USD","IE0009355771.USD","BK4532","LU0225284248.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0432979614.USD","LU2360032135.SGD","BK4559","LU0267386448.USD","LU1236620750.USD","LU1261432733.SGD","LU1670711040.USD","LU1670711123.USD","LU1983299246.USD","IE00BFXG1179.USD","LU1430594728.SGD","FTXH","LU1093756168.USD","LU1571399168.USD","LU2125154778.USD","LU1323610961.USD","LU1868837300.USD","LU1718418525.SGD","LU1236620834.HKD","IE0002141913.USD","LU1291159041.SGD","LU0868494617.USD","BK4588","IHE","BK4585","LU0114720955.EUR","LU0237698245.USD","LU0306806265.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","BK4007","LU1032466523.USD","LU1670710588.SGD","LU2133065610.SGD","UUP","UDN","LU1868837136.USD","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679033214","title":"百时美施贵宝第三季度业绩超预期，上调2026年营收预期，盘前股价上涨2.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2679033214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679033214?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:04","pubTimestamp":1793271866,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FTXH","IHE","LU2360032135.SGD","LU2242646821.SGD","LU0058720904.USD","LU0321505868.SGD","IE0009355771.USD","LU0237698245.USD","LU2133065610.SGD","LU1236620750.USD","LU0289739699.SGD","LU1093756325.SGD","LU1670711040.USD","LU0456855351.SGD","LU0985481810.HKD","LU0321505439.SGD","LU1430594728.SGD","LU1883839398.USD","IE00B2B36J28.USD","IE00BFXG1179.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1261432733.SGD","LU2125154935.USD","LU0225284248.USD","LU1032466523.USD","LU1868836757.USD","LU0306807586.USD","BK4534","LU1718418525.SGD","LU0096364046.USD","LU2242652126.USD","LU1670710588.SGD","IE00BJT1NW94.SGD","LU1868837136.USD","LU0225771236.USD","LU2125154778.USD","LU1074936037.SGD","BK4532","BK4588","LU1093756168.USD","LU1571399168.USD","BK4559","LU1670710661.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU0267386448.USD","LU0432979614.USD","BMY","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679408205","title":"百时美施贵宝上调2026年营收预期，三季度新药需求向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2679408205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679408205?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:00","pubTimestamp":1793271605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","IE0009355771.USD","LU1032466523.USD","LU2125154778.USD","LU1670710588.SGD","LU0225284248.USD","LU1670710661.SGD","LU0432979614.USD","BMY","IHE","LU1074936037.SGD","LU1430594728.SGD","BK4534","IE00BFXG1179.USD","BK4588","LU1093756168.USD","LU2242652126.USD","LU0321505439.SGD","LU0225771236.USD","LU0868494617.USD","LU2360032135.SGD","LU0096364046.USD","LU1868837136.USD","IE00BJT1NW94.SGD","LU1883839398.USD","LU1236620750.USD","LU2125154935.USD","LU1093756325.SGD","LU1670711040.USD","BK4532","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU1571399168.USD","LU1261432733.SGD","FTXH","LU0267386448.USD","LU0289739699.SGD","LU0114720955.EUR","LU2242646821.SGD","BK4559","LU1718418525.SGD","IE00BFTCPJ56.SGD","LU0321505868.SGD","LU0456855351.SGD","LU1868836757.USD","LU1291159041.SGD","LU2133065610.SGD","LU0237698245.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679408190","title":"百时美施贵宝第三季度营收130.7亿美元，预期为127.1亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2679408190","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679408190?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:59","pubTimestamp":1793271550,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFXG1179.USD","LU0321505868.SGD","LU1868836914.USD","BMY","LU2360032135.SGD","LU2125154778.USD","LU0267386448.USD","LU2596442595.SGD","LU1670710661.SGD","LU2242652126.USD","LU1074936037.SGD","LU0868494617.USD","LU1989771016.USD","LU1670710588.SGD","LU1236620834.HKD","LU0306806265.USD","LU0061475181.USD","LU2242646821.SGD","IHE","FTXH","LU0882574055.USD","LU1236620750.USD","LU0225771236.USD","LU1093756168.USD","LU0058720904.USD","BK4581","IE0002141913.USD","LU1883839398.USD","LU1032466523.USD","LU0289739699.SGD","LU1323610961.USD","LU1093756325.SGD","LU1868837136.USD","LU0114720955.EUR","LU1291159041.SGD","LU1670711123.USD","LU1430594728.SGD","BK4534","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","LU0321505439.SGD","LU0985481810.HKD","LU1868837300.USD","LU1585245621.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678432656","title":"国内外两大巨头纷纷大动作，行业传统范式正在重塑！机构建议把握商业验证与临床验证两条主线，产业链相关公司梳理","url":"https://stock-news.laohu8.com/highlight/detail?id=2678432656","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678432656?lang=zh_cn&edition=full","pubTime":"2026-10-28 13:32","pubTimestamp":1793165520,"startTime":"0","endTime":"0","summary":"聊点事：当地时间10月27日，Anthropic宣布，其在加速药物研发方面取得初步进展。Anthropic生命科学团队已与百时美施贵宝、Generate Biomedicines等六家新药研发机构建立深度研究合作，并启 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261028/c681180651.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261028/c681180651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0868494617.USD","LU0306806265.USD","LU2596442595.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4559","LU0456855351.SGD","BK4585","LU1670711123.USD","LU0321505439.SGD","LU1718418525.SGD","LU2125154935.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU0114720955.EUR","LU1236620750.USD","LU1261432733.SGD","LU2360032135.SGD","LU1883839398.USD","LU2125154778.USD","LU1670710661.SGD","LU1093756325.SGD","LU0225771236.USD","LU1585245621.USD","LU2133065610.SGD","LU1074936037.SGD","LU0289739699.SGD","LU1291159041.SGD","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0237698245.USD","LU1868837300.USD","BK4532","LU1032466523.USD","LU1983299246.USD","IE00BSNM7G36.USD","LU0321505868.SGD","BMY","LU1868837136.USD","LU1670711040.USD","BK4581","LU0985481810.HKD","LU1868836591.USD","LU1868836914.USD","LU1236620834.HKD","IE0009355771.USD","FTXH","LU2242652126.USD","LU1571399168.USD","IHE","LU0306807586.USD","LU2242646821.SGD","LU1989771016.USD","BK4588","IE00BFXG1179.USD","LU0096364046.USD","LU0225284248.USD","LU0267386448.USD","LU1868836757.USD","LU1430594728.SGD","LU1323610961.USD","BK4534","LU1093756168.USD","LU0432979614.USD","LU1670710588.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678155229","title":"派珀·桑德勒将百时美施贵宝目标价从82美元下调至78美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2678155229","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678155229?lang=zh_cn&edition=full","pubTime":"2026-10-26 11:58","pubTimestamp":1792987137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1670711123.USD","LU1585245621.USD","BK4585","LU0882574055.USD","LU0306806265.USD","IE00BJJMRZ35.SGD","LU1236620834.HKD","BK4588","LU1868837136.USD","UUP","LU0237698245.USD","BK4581","LU1883839398.USD","BK4534","LU0432979614.USD","BMY","LU1032466523.USD","LU1868837300.USD","IE00BFXG1179.USD","LU1236620750.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1093756325.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU1868836591.USD","LU1989771016.USD","IE0009355771.USD","LU2360032135.SGD","LU0868494617.USD","LU2133065610.SGD","LU1868836757.USD","LU1261432733.SGD","UDN","IHE","BK4559","LU1983299246.USD","LU0321505868.SGD","FTXH","LU0061475181.USD","LU0096364046.USD","LU0306807586.USD","LU1074936037.SGD","LU1670710661.SGD","LU2596442595.SGD","LU0985481810.HKD","LU1670711040.USD","LU1571399168.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678018218","title":"生物科技公司和百时美施贵宝公布了 Pumitamig 在免疫治疗联合化疗后进展的晚期非小细胞肺癌中的全球 2 期积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2678018218","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678018218?lang=zh_cn&edition=full","pubTime":"2026-10-25 15:31","pubTimestamp":1792913467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1670710661.SGD","LU1868836914.USD","BK4581","LU2596442595.SGD","LU1323610961.USD","LU1670710588.SGD","LU0321505868.SGD","IE0009355771.USD","LU1032466523.USD","LU1291159041.SGD","LU0237698245.USD","MEDX","LU0985481810.HKD","LU0061475181.USD","IE00BFTCPJ56.SGD","BK4007","XBI","LU2133065610.SGD","FTXH","GDOC","LU2242646821.SGD","LU1093756168.USD","LU0114720955.EUR","LU1074936037.SGD","LU0456855351.SGD","LU1093756325.SGD","IE00BSNM7G36.USD","LU0432979614.USD","LU1236620750.USD","LU1868837300.USD","LU1868837136.USD","LU0306807586.USD","IE00B2B36J28.USD","LU2125154778.USD","LU1868836757.USD","BMY","SYNB","LU0868494617.USD","LU0225284248.USD","IBBJ","LU1670711123.USD","LU1571399168.USD","IHE","BK4532","LU1670711040.USD","AGNG","LU1236620834.HKD","LNGR","IEIH","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677276908","title":"CLDN18.2靶向ADC 3期研究达到双主要终点；双靶点ADC 3期结果积极……","url":"https://stock-news.laohu8.com/highlight/detail?id=2677276908","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677276908?lang=zh_cn&edition=full","pubTime":"2026-10-24 07:35","pubTimestamp":1792798500,"startTime":"0","endTime":"0","summary":" CLDN18.2靶向ADC国际3期研究达到双主要终点，延长胃癌患者PFS和OS 武田(Takeda)和信达生物(Innovent Biologics)公布了在研CLDN18.2靶向抗体偶联药物(ADC)arcotatug tava ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261024/c681047440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["IE00BFXG1179.USD","LU0321505868.SGD","BK4211","BMY","BK4139","LU2360032135.SGD","LU2596442595.SGD","LU0237698245.USD","LU1670710661.SGD","LU1074936037.SGD","BK4532","LU0306806265.USD","LU0061475181.USD","LU2242646821.SGD","PFS","IHE","FTXH","LU1236620750.USD","ADC","LU1983299246.USD","NETL","ORR","LU1261432733.SGD","BK4231","BK4581","LU0096364046.USD","GMAB","LU2133065610.SGD","LU1032466523.USD","LU1868837136.USD","LU0114720955.EUR","LU1291159041.SGD","FFBC","LU1670711123.USD","BK4195","LU1430594728.SGD","BK4534","IE0009355771.USD","BK4585","LU1670711040.USD","LU0985481810.HKD","LU2125154935.USD","LU0456855351.SGD","IE00BSNM7G36.USD","ITT","LU1571399168.USD","BK4559","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677973041","title":"百时美施贵宝披露早期多发性硬化症试验中出现患者死亡；股价下跌2.5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2677973041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677973041?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:59","pubTimestamp":1792767560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2125154935.USD","IE0002141913.USD","LU1883839398.USD","LU0267386448.USD","LU1236620834.HKD","LU0061475181.USD","LU0321505439.SGD","LU0225284248.USD","LU1670711040.USD","BMY","LU1670710661.SGD","LU1074936037.SGD","LU0868494617.USD","LU1585245621.USD","LU2360032135.SGD","LU2133065610.SGD","LU0096364046.USD","LU1093756325.SGD","BK4581","LU1323610961.USD","IE0009355771.USD","LU1291159041.SGD","LU0432979614.USD","LU0225771236.USD","BK4559","LU1983299246.USD","BK4585","IE00BSNM7G36.USD","BK4007","LU1236620750.USD","LU1093756168.USD","LU1989771016.USD","LU2125154778.USD","BK4532","LU0985481810.HKD","BK4534","LU0237698245.USD","FTXH","LU1868836757.USD","LU1868836914.USD","LU0456855351.SGD","LU2596442595.SGD","LU1261432733.SGD","LU2242646821.SGD","LU2242652126.USD","LU1868837136.USD","LU0882574055.USD","IHE","LU1670710588.SGD","LU1032466523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677897324","title":"百时美施贵宝表示，一名多发性硬化症患者在CAR-T研究中死于脓毒性肺炎。","url":"https://stock-news.laohu8.com/highlight/detail?id=2677897324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677897324?lang=zh_cn&edition=full","pubTime":"2026-10-23 22:52","pubTimestamp":1792767128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1670711123.USD","LU1430594728.SGD","LU2125154935.USD","LU1093756325.SGD","LU0096364046.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU1868836591.USD","BK4585","LU1585245621.USD","IHE","FTXH","LU0432979614.USD","LU2360032135.SGD","LU1291159041.SGD","LU1032466523.USD","LU1670710588.SGD","LU0237698245.USD","LU1670710661.SGD","LU0267386448.USD","LU0868494617.USD","LU1670711040.USD","LU0985481810.HKD","LU1983299246.USD","LU1989771016.USD","LU1883839398.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1074936037.SGD","BK4559","LU0225771236.USD","IE00BFXG1179.USD","LU1718418525.SGD","LU1868837136.USD","LU1236620834.HKD","LU1868837300.USD","LU2125154778.USD","IE0009355771.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","BK4007","LU0321505868.SGD","LU0225284248.USD","BMY","LU0306807586.USD","BK4534","LU0456855351.SGD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677192761","title":"TEMPUS AI：百时美施贵宝将获得该公司多模式肿瘤学数据的授权，授权期限至2031年，以支持生物和临床洞察的识别。","url":"https://stock-news.laohu8.com/highlight/detail?id=2677192761","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677192761?lang=zh_cn&edition=full","pubTime":"2026-10-23 21:01","pubTimestamp":1792760499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1032466523.USD","LU0237698245.USD","LU2242646821.SGD","LU0225284248.USD","BMY","LU1074936037.SGD","LU1868837136.USD","IE00BFTCPJ56.SGD","FTXH","BK4007","LU1323610961.USD","LU1883839398.USD","LU1236620834.HKD","IHE","VTHR","BK4588","LU1571399168.USD","IE00BSNM7G36.USD","AGIX","LU0306807586.USD","LU0321505868.SGD","LU1236620750.USD","BK4559","LU1585245621.USD","LU1868836914.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU0061475181.USD","CANC","QTOC","LU0985481810.HKD","CHAT","LU1718418525.SGD","WTAI","IE00B2B36J28.USD","IE0002141913.USD","IE00BFXG1179.USD","IE0009355771.USD","LU1670710588.SGD","BK4532","LU2125154778.USD","AIPO","LU2596442595.SGD","LU0868494617.USD","BK4581","LU1261432733.SGD","BK4585","ARTY","LU1670710661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677294109","title":"百时美施贵宝公司：在第三阶段乳腺癌研究中，伊沙贝木单抗将疾病进展或死亡的风险降低了59%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2677294109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677294109?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:31","pubTimestamp":1792755089,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0868494617.USD","BK4007","LU0321505439.SGD","BK4532","LU0096364046.USD","LU2125154935.USD","LU0237698245.USD","LU1571399168.USD","BMY","LU1670710661.SGD","LU1868836757.USD","LU2125154778.USD","LU1868837300.USD","IHE","LU1093756325.SGD","LU0432979614.USD","IE0002141913.USD","LU0267386448.USD","FTXH","IE00BSNM7G36.USD","LU1989771016.USD","LU0225284248.USD","LU0456855351.SGD","LU1868837136.USD","LU2242652126.USD","LU1983299246.USD","BK4585","LU1236620834.HKD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU0306806265.USD","LU1868836914.USD","IE00B2B36J28.USD","LU1236620750.USD","BK4559","LU1670711040.USD","LU1883839398.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2242646821.SGD","BK4534","LU1718418525.SGD","LU0321505868.SGD","LU1670710588.SGD","LU1074936037.SGD","LU1670711123.USD","LU0985481810.HKD","LU2596442595.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115431138","title":"异动解读｜施贵宝盘中上涨3.03%，机构看好第三季度收入表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1115431138","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115431138?lang=zh_cn&edition=full","pubTime":"2026-10-23 00:30","pubTimestamp":1792686647,"startTime":"0","endTime":"0","summary":"10月23日，施贵宝盘中上涨3.03%，报62.97美元/股，成交额2.11亿美元。此次异动的直接催化来自财报前预期改善。市场消息显示，有机构预计公司第三季度收入将超过市场一致预期，驱动因素包括Eliquis、Revlimid等成熟产品销售强于预期，以及增长产品继续放量。与此同时，市场对公司估值仍存分歧：此前有卖方将目标价下调至60美元，也有机构将目标价上调至76美元、82美元。临近10月29日财报披露，资金更关注业绩兑现与新药管线进展。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"施贵宝盘中拉升，三季报预期获看好","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153694524","title":"财报前瞻 | 施贵宝本季度营收预计增7.96%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1153694524","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153694524?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:27","pubTimestamp":1792628865,"startTime":"0","endTime":"0","summary":"施贵宝将于2026年10月29日发布季度财报，市场预期营收延续增长而利润指标承压，关注核心产品与增长组合的兑现度。市场一致预期显示，本季度施贵宝营收预计为127.53亿美元，同比增加7.96%；调整后每股收益预计为1.23美元，同比下降18.72%；息税前利润预计为33.37亿美元，同比下降7.19%。公司层面或市场公开信息未提供本季度的毛利率及净利润预测数据，若后续公司在财报中给出指引，应以正式披露为准。近期卖方观点中，偏谨慎与下调取向占多数。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 施贵宝本季度营收预计增7.96%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177793379","title":"异动解读｜施贵宝盘中上涨3.46%，机构看好第三季度收入表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1177793379","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177793379?lang=zh_cn&edition=full","pubTime":"2026-10-20 21:38","pubTimestamp":1792503509,"startTime":"0","endTime":"0","summary":"10月20日，施贵宝盘中上涨3.46%，报60.34美元/股，成交额4237.42万美元。最新催化来自机构观点上修预期。市场消息显示，有机构预计公司第三季度收入将超过市场一致预期，驱动因素包括Eliquis、Revlimid等成熟产品销售强于预期，以及增长产品放量。不过，近期卖方也下调了公司目标价至60美元，显示市场对其估值与管线兑现仍存分歧。临近10月29日财报披露时点，资金更关注业绩兑现与新药管线进展。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"施贵宝盘中异动拉升，机构看好Q3收入超预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0409},{"period":"3month","weight":-0.0399},{"period":"6month","weight":0.1065},{"period":"1year","weight":0.3326},{"period":"ytd","weight":0.152}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月在美国德拉瓦州注册成立，源自于1887年在纽约创办的企业，并在1989年因合并而重命名。作为一家生物制药公司，百时美施贵宝专注于创新药物的发现、开发、许可、生产、营销和销售，以对抗严重疾病。公司的战略方法结合了大型制药公司的资源和规模，以及生物技术行业特有的灵活性和创新重点。百时美施贵宝优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物，旨在提供长期价值和竞争优势。作为全球研究型制药公司，百时美施贵宝的产品在全球范围内销售，服务于包括批发商、分销商和特药药房在内的多种实体，并在多个国家保持着重要的生产运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.478261,"avgChangeRate":-0.011323},{"month":2,"riseRate":0.565217,"avgChangeRate":0.011855},{"month":3,"riseRate":0.630435,"avgChangeRate":0.007963},{"month":4,"riseRate":0.468085,"avgChangeRate":-0.005808},{"month":5,"riseRate":0.553191,"avgChangeRate":0.001393},{"month":6,"riseRate":0.617021,"avgChangeRate":0.009381},{"month":7,"riseRate":0.425532,"avgChangeRate":0.001143},{"month":8,"riseRate":0.531915,"avgChangeRate":-0.000512},{"month":9,"riseRate":0.510638,"avgChangeRate":0.008315},{"month":10,"riseRate":0.595745,"avgChangeRate":0.024614},{"month":11,"riseRate":0.617021,"avgChangeRate":0.021727},{"month":12,"riseRate":0.630435,"avgChangeRate":0.022265}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}